연구동향 분석
박사

마이크로 RNA-206의 TM4SF1 조절을 통한 대장암 진행의 억제

서승영 2019년

논문상세정보
인용/피인용
' 마이크로 RNA-206의 TM4SF1 조절을 통한 대장암 진행의 억제' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Micro RNA-206
  • TM4SF1
  • colorectal cancer
  • emt
  • 대장암
  • 마이크로 RNA-206
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
384 0

0.0%

' 마이크로 RNA-206의 TM4SF1 조절을 통한 대장암 진행의 억제' 의 참고문헌

  • Zhou. L, Chen. J, Li. Z, Li. X, Hu. X, Huang. Y, et al. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One 5 (2010) e15224.
  • Zhang. L, Liu. X, Jin. H, Guo. X, Xia. L, Chen. Z, et al. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett. 332 (2013) 94–101.
  • Zhang, T, Liu. M, Wang. C, Lin. C, Sun. Y, Jin. D. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res. 31 (2011) 3859–3863.
  • Yin. K, Yin. W, Wang. Y, Zhou. L, Liu. Y, Yang. G, et al. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-beta signaling in estrogen receptor positive breast cancer cells. Oncotarget. 7 (2016) 24537–24548.
  • Ye. Y.N, Wu. W.K, Shin. V.Y, Bruce. I.C, Wong. B.C, Cho. C.H. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis. 26 (2005) 827–834.
  • Yang. J.C, Zhang. Y, He. S.J, Li. M.M, Cai. X.L, Wang. H, et al. TM4SF1 promotes metastasis of pancreatic cancer via regulating the expression of DDR1. Sci. Rep. 7 (2017) 4589.
  • Wright. M.D, Ni. J, Rudy. G.B. The L6 membrane proteins–a new four-transmembrane superfamily. Protein Sci. 9 (2000) 1594–1600.
  • Winter. J, Jung. S, Keller. S, Gregory. R.I, Diederichs. S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11 (2009) 228–234.
  • Wang. X.W, Xi. X.Q, Wu. J, Wan. Y.Y, Hui. H.X, Cao. X.F. MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. Oncol. Rep. 33 (2015) 1402–1410.
  • Wang. X, Ling. C, Bai. Y, Zhao. J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat. Rec. (Hoboken) 294 (2011) 88–92.
  • Vu. T, Datta. P.K. Regulation of EMT in colorectal cancer: a culprit in metastasis. Cancers. 9 (2017) 171.
  • Vickers. M.M, Bar. J, Gorn-Hondermann. I, Yarom. N, Daneshmand. M, Hanson. J.E, et al. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin. Exp. Metastasis. 29 (2012) 123–132.
  • Tong. D, Liu. Q, Liu. G, Xu. J, Lan. W, Jiang. Y, et al. Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis. Cancer Lett. 389 (2017) 23–32.
  • Tenesa. A, Dunlop. M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 10 (2009) 353–358.
  • Taulli. R, Bersani. F, Foglizzo. V, Linari. A, Vigna. E, Ladanyi. M, et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J. Clin. Invest. 119 (2009) 2366–2378.
  • Sun. Y, Xu. Y, Xu. J, Lu. D, Wang. J. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway. Int. J. Clin. Exp. Pathol. 8 (2015) 9081–9088.
  • Sun. P, Sun. D, Wang. X, Liu. T, Ma. Z, Duan. L. miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer. Cancer Biomark. 15 (2015) 391–396.
  • Ruan. D. and So. S.P. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci. 116 (2014) 43–50.
  • Ren. X.L, He. G.Y, Li. X.M, Men. H, Yi. L.Z, Lu. G.F, et al. MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2. J. Cancer Res. Clin. Oncol. 142 (2016) 581–592.
  • Qiu. X, Cheng. J.C, Chang. H.M, Leung. P.C. COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion. Endocr. Relat. Cancer. 21 (2014) 533–543.
  • Pozzi. A, Yan. X, Macias-Perez. I, Wei. S, Hata. A.N, Breyer. R.M, et al. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. J. Biol. Chem. 279 (2004) 29797–29804.
  • Park. Y.S, Kim. N.I, Lee. J.S, Choi. J.H, Iim. C.Y, Jeon. D.W, et al. Cyclooxgenase-2 expression in chronic inflammatory bowel disease: comparing of immunohistochemical stain to real-time PCR. Intest. Res. 6 (2008) 128–134.
  • Park. Y.R, Lee. S.T, Kim. S.L, Liu. Y.C, Lee. M.R, Shin. J.H, et al. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. Int. J. Oncol. 48 (2016) 2135–2143.
  • Park. Y.R, Kim. S.L, Lee. M.R, Seo. S.Y, Lee. J.H, Kim. S.H, et al. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer. J. Cancer Res. Clin. Oncol. 143 (2017) 1915–1927.
  • Parasramka. M.A, Dashwood. W.M, Wang. R, Saeed. H.H, Williams. D.E, Ho. E, et al. A role for low-abundance miRNAs in colon cancer: the miR-206/Kruppel-like factor 4 (KLF4) axis. Clin. Epigenetics. 4 (2012) 16.
  • Marken. J.S, Schieven. G.L, Hellstrom. I, Hellstrom. K.E, Aruffo. A. Cloning and expression of the tumor-associated antigen L6. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3503–3507.
  • Mantovani. A, Allavena. P, Sica. A, Balkwill. F. Cancer-related inflammation. Nature. 454 (2008) 436–444.
  • Liu. X, Ji. Q, Ye. N, Sui. H, Zhou. L, Zhu, H. Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway. PLoS ONE 10 (2015) e0123478.
  • Liu. F, Zhao. X, Qian. Y, Zhang. J, Zhang. Y, Yin. R. MiR-206 inhibits head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway. Biomed. Pharmacother. 96 (2017) 229–237.
  • Lin. T.Y, Fan. C.W, Maa. M.C, Leu. T.H. Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation. Biomedicine 5 (2015) 33-38.
  • Lekishvili. T, Fromm. E, Mujoomdar. M, Berditchevski. F. The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility. J. Cell Sci. 121 (2008) 685–694.
  • Kondo. N, Toyama. T, Sugiura. H, Fujii. Y, Yamashita. H. miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 68 (2008) 5004–5008.
  • Kleivi. K, Lind. G.E, Diep. C.B, Meling. G.I, Brandal. L.T, Nesland. J.M, et al. Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol. Cancer. 6 (2007) 2.
  • Jemal. A, Murray. T, Ward. E, Samuels. A, Tiwari. R.C, Ghafoor. A, et al. Cancer statistics, CA Cancer J. Clin. 55 (2005) 10–30.
  • Hull. M.A, Ko. S.C, Hawcroft. G. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther. 3 (2004) 1031–1039.
  • Huang. Y.K, Fan. X.G, Qiu. F. TM4SF1 promotes proliferation, invasion, and metastasis in human liver cancer cells. Int. J. Mol. Sci. 17 (2016) 661.
  • Hsu. H.H, Lin. Y.M, Shen. C.Y, Shibu. M.A, Li. S.Y, Chang. S.H, et al. Prostaglandin E2-induced COX-2 expressions via EP2 and EP4 signaling pathways in human LoVo colon cancer cells. Int. J. Mol. Sci. 18 (2017) 1132.
  • Hellstrom. I, Garrigues. U, Lavie. E, Hellstrom. K.E. Antibody-mediated killing of human tumor cells by attached effector cells. Cancer Res. 48 (1988) 624–627.
  • Heerboth. S, Housman. G, Leary. M, Longacre. M, Byler. S, Lapinska. K, et al. EMT and tumor metastasis. Clin. Transl. Med. 4 (2015) 6.
  • Hao. W, Luo. W, Bai. M, Li. J, Bai. X, Guo, J. MicroRNA-206 inhibited the progression of glioblastoma through BCL-2. J. Mol. Neurosci. 60 (2016) 531–538.
  • George. R.J, Sturmoski. M.A, Anant. S, Houchen. C.W. EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway. Prostaglandins Other Lipid Mediat. 83 (2007) 112–120.
  • Gan. L, Qiu. Z, Huang. J, Li. Y, Huang. H, Xiang. T, et al. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway. Int. J. Biol. Sci. 12 (2016) 1533–1543.
  • Fujino. H, Toyomura. K, Chen. X.B, Regan. J.W, Murayama. T. Prostaglandin E(2) regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells. Biochem. Pharmacol. 81 (2011) 379–387.
  • Dubois. R.N. Role of inflammation and inflammatory mediators in colorectal cancer. Trans. Am. Clin. Climatol. Assoc. 125 (2014) 358–372, discussion 372–373.
  • Chen. X, Yan. Q, Li. S, Zhou. L, Yang. H, Yang. Y, et al. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett. 314 (2012) 41–53.
  • Chen. Q.Y, Jiao. D.M, Wu. Y.Q, Chen. J, Wang. J, Tang. X.L, et al. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Oncotarget. 7 (2016) 18247–18261.
  • Chandramouli. A, Mercado-Pimentel. M.E, Hutchinson. A, Gibadulinova. A, Olson. E.R, Dickinson. S. The induction of S100p expression by the Prostaglandin E(2) (PGE(2))/EP4 receptor signaling pathway in colon cancer cells. Cancer Biol. Ther. 10 (2010) 1056–1066.
  • Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116 (2004) 281–297.